CLDX · Celldex Therapeutics, Inc.
$37.52
+1.94 (+5.44%)
At close · Jul 29
Market Cap
$2.94B
Shares
78.49M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-15 | 2026-07-10 | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-26 | 2026-06-25 | |
| 8-K | 2026-05-07 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| DEF 14A | 2026-04-29 | 2026-06-25 | |
| 8-K | 2026-04-02 | 2026-04-01 | |
| 8-K | 2026-02-25 | — | |
| 10-K | 2026-02-25 | 2025-12-31 | |
| 8-K | 2025-11-10 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-08-19 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-06-06 | 2025-06-05 | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| DEF 14A | 2025-04-21 | 2025-06-05 | |
| 8-K | 2025-02-27 | — | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2024-11-06 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-08-08 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-06-14 | 2024-06-13 | |
| 8-K | 2024-05-06 | — | |
| 10-Q | 2024-05-06 | 2024-03-31 | |
| DEF 14A | 2024-04-25 | 2024-06-13 | |
| 8-K | 2024-03-01 | 2024-02-28 | |
| 8-K | 2024-02-26 | — | |
| 10-K | 2024-02-26 | 2023-12-31 | |
| 8-K | 2023-11-08 | 2023-11-07 | |
| 8-K | 2023-11-06 | 2023-11-05 | |
| 8-K | 2023-11-02 | — | |
| 10-Q | 2023-11-02 | 2023-09-30 | |
| 10-Q | 2023-08-08 | 2023-06-30 | |
| 8-K | 2023-08-08 | — | |
| 8-K | 2023-06-15 | — | |
| 10-Q | 2023-05-04 | 2023-03-31 | |
| 8-K | 2023-05-04 | — | |
| DEF 14A | 2023-04-25 | 0001-01-01 | |
| 8-K | 2023-03-22 | 2023-03-21 | |
| 8-K | 2023-02-28 | — | |
| 10-K | 2023-02-28 | 2022-12-31 | |
| 8-K | 2023-02-21 | 2023-02-16 | |
| 10-Q | 2022-11-09 | 2022-09-30 | |
| 8-K | 2022-11-09 | — | |
| 10-Q | 2022-08-08 | 2022-06-30 | |
| 8-K | 2022-08-08 | — | |
| 8-K | 2022-07-18 | 2022-07-15 |
Showing 1–50 of 87 filings
Key facts
CIK
744218
CUSIP
15117B202
13F (30d)
35 filings
35 filers
Visit website
Investor relations